Data-driven methodology for discovery and response to pulmonary symptomology in hypertension through AI and machine learning: Application to COVID-19 related pharmacovigilance

Xuan Xu, Jessica Kawakami, Nuwan Indika Millagaha Gedara, Jim Riviere, Emma Meyer, Gerald J. Wyckoff, Majid Jaberi-Douraki
doi: https://doi.org/10.1101/2021.06.07.21258497

Article Information

doi 
https://doi.org/10.1101/2021.06.07.21258497
History 
  • July 2, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Xuan Xu1,2,3,
  2. Jessica Kawakami1,4,5,
  3. Nuwan Indika Millagaha Gedara1,3,6,
  4. Jim Riviere1,7,
  5. Emma Meyer1,4,
  6. Gerald J. Wyckoff1,4,5 and
  7. Majid Jaberi-Douraki1,2,3,*
  1. 11DATA Consortium, www.1DATA.life, USA
  2. 2Department of Mathematics, Kansas State University
  3. 3Kansas State University Olathe, Olathe, KS 66061-1304
  4. 4School of Pharmacy, Division of Pharmacology and Pharmaceutical Sciences, University of Missouri-Kansas City
  5. 5Molecular Biology and Biochemistry, School of Biological and Chemical Sciences, University of Missouri-Kansas City
  6. 6Department of Business Economics, University of Colombo, Sri Lanka
  7. 7Kansas State University and North Carolina State University
  1. ↵*Correspondence:
    Majid Jaberi-Douraki, jaberi{at}ksu.edu
Back to top
Posted July 02, 2021.
Download PDF
Data/Code
Email
Data-driven methodology for discovery and response to pulmonary symptomology in hypertension through AI and machine learning: Application to COVID-19 related pharmacovigilance
Xuan Xu, Jessica Kawakami, Nuwan Indika Millagaha Gedara, Jim Riviere, Emma Meyer, Gerald J. Wyckoff, Majid Jaberi-Douraki
medRxiv 2021.06.07.21258497; doi: https://doi.org/10.1101/2021.06.07.21258497
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area